Somalia
Hepatitis B
Download HBV dataPrevalence of chronic HBV (HBsAg+)
National
Download| Value (%) | Year | Type | Source |
|---|---|---|---|
| 13.45 (11.04 - 16.37) | 2015 | Modelled | WHO |
| 14.77 (13.77 - 15.84) | 2013 | Modelled | Schweitzer et al, 2015 |
| 11.06 (10.13 - 12.04) | 2019 | Modelled | IHME, GBD 2019 (accessed 2020) |
| 12.3 (11.33 - 13.34) | 2018 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 12.53 (11.54 - 13.63) | 2017 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 12.54 (11.54 - 13.62) | 2016 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 12.54 (11.50 - 13.66) | 2015 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 12.62 (11.59 - 13.71) | 2014 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 12.77 (11.74 - 13.89) | 2013 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 12.96 (11.92 - 14.06) | 2012 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 13.13 (12.05 - 14.24) | 2011 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 13.21 (12.12 - 14.34) | 2010 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 13.23 (12.18 - 14.33) | 2009 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 13.25 (12.17 - 14.36) | 2008 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 13.27 (12.19 - 14.41) | 2007 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 13.28 (12.23 - 14.42) | 2006 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 13.3 (12.19 - 14.44) | 2005 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 13.32 (12.23 - 14.49) | 2004 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 13.34 (12.28 - 14.50) | 2003 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 13.37 (12.29 - 14.54) | 2002 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 13.39 (12.31 - 14.57) | 2001 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 13.42 (12.36 - 14.59) | 2000 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 13.45 (12.39 - 14.61) | 1999 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 13.49 (12.44 - 14.66) | 1998 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 13.54 (12.44 - 14.69) | 1997 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 13.58 (12.44 - 14.72) | 1996 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 13.61 (12.46 - 14.79) | 1995 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 13.63 (12.49 - 14.83) | 1994 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 13.66 (12.52 - 14.83) | 1993 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 13.68 (12.55 - 14.84) | 1992 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 13.7 (12.53 - 14.87) | 1991 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 13.72 (12.55 - 14.92) | 1990 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 11.81 (10.85 - 12.83) | 2019 | Modelled | IHME, GBD 2019 (accessed 2022) |
Showing out of
Show more
Children under-5 years
Download| Value (%) | Year | Type | Source |
|---|---|---|---|
| 10.54 (8.34 - 13.11) | 2015 | Modelled | WHO |
| 4.39 (3.64 - 5.26) | 2019 | Modelled | IHME, GBD 2019 (accessed 2020) |
| 4.92 (4.10 - 5.85) | 2019 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 5.5 (4.64 - 6.51) | 2018 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 5.78 (4.83 - 6.86) | 2017 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 5.78 (4.83 - 6.86) | 2016 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 5.77 (4.78 - 6.88) | 2015 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 6.11 (5.07 - 7.25) | 2014 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 6.87 (5.70 - 8.13) | 2013 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 7.77 (6.43 - 9.20) | 2012 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 8.54 (7.09 - 10.08) | 2011 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 8.89 (7.36 - 10.49) | 2010 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 8.92 (7.42 - 10.52) | 2009 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 8.93 (7.50 - 10.51) | 2008 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 8.93 (7.51 - 10.50) | 2007 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 8.92 (7.52 - 10.55) | 2006 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 8.93 (7.49 - 10.56) | 2005 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 8.94 (7.53 - 10.54) | 2004 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 8.96 (7.57 - 10.57) | 2003 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 8.97 (7.58 - 10.54) | 2002 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 8.99 (7.56 - 10.56) | 2001 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 9.01 (7.54 - 10.61) | 2000 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 9.03 (7.56 - 10.67) | 1999 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 9.06 (7.57 - 10.78) | 1998 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 9.1 (7.62 - 10.86) | 1997 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 9.14 (7.66 - 10.87) | 1996 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 9.16 (7.67 - 10.92) | 1995 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 9.17 (7.68 - 10.93) | 1994 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 9.19 (7.70 - 10.94) | 1993 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 9.2 (7.71 - 10.94) | 1992 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 9.23 (7.71 - 10.99) | 1991 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 9.26 (7.73 - 11.03) | 1990 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 6.32 (5.51 - 7.24) | 2020 | Modelled | WHO |
Showing out of
Show more
Number of people living with chronic HBV
National
Download| Value | Year | Type | Source |
|---|---|---|---|
| 2,249,730 (2,061,140 - 2,449,740) | 2019 | Modelled | IHME, GBD 2019 (accessed 2020) |
| 2,332,010 (2,143,610 - 2,533,550) | 2019 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 2,346,750 (2,156,900 - 2,545,360) | 2018 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 2,307,730 (2,125,230 - 2,511,540) | 2017 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 2,225,230 (2,046,950 - 2,417,830) | 2016 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 2,140,620 (1,962,680 - 2,332,850) | 2015 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 2,070,750 (1,898,410 - 2,249,210) | 2014 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 2,022,010 (1,859,880 - 2,196,240) | 2013 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1,980,170 (1,818,920 - 2,150,960) | 2012 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1,937,700 (1,781,330 - 2,102,390) | 2011 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1,897,900 (1,740,530 - 2,060,290) | 2010 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1,861,500 (1,710,750 - 2,018,150) | 2009 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1,818,510 (1,671,170 - 1,970,150) | 2008 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1,768,860 (1,627,750 - 1,919,300) | 2007 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1,716,170 (1,579,390 - 1,863,390) | 2006 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1,658,380 (1,525,510 - 1,804,270) | 2005 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1,601,660 (1,472,220 - 1,739,820) | 2004 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1,546,410 (1,422,080 - 1,680,110) | 2003 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1,489,290 (1,368,820 - 1,616,510) | 2002 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1,431,230 (1,316,770 - 1,555,820) | 2001 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1,375,320 (1,265,790 - 1,497,280) | 2000 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1,323,710 (1,220,400 - 1,440,070) | 1999 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1,273,850 (1,174,040 - 1,384,130) | 1998 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1,223,620 (1,124,010 - 1,328,120) | 1997 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1,177,770 (1,081,350 - 1,277,380) | 1996 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1,136,630 (1,041,550 - 1,237,110) | 1995 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1,095,130 (1,003,590 - 1,191,550) | 1994 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1,056,500 (966,908 - 1,147,800) | 1993 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1,016,630 (932,534 - 1,102,590) | 1992 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 974,560 (891,048 - 1,057,840) | 1991 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 964,822 (882,603 - 1,049,140) | 1990 | Modelled | IHME, GBD 2019 (accessed 2022) |
Showing out of
Show more
HBV-related death rate
National
Download| Value (per 100,000) | Year | Type | Source |
|---|---|---|---|
| 7.85 (4.88 - 13) | 2019 | Modelled | IHME, GBD 2019 (accessed 2020) |
| 10.03 (6.37 - 16.35) | 1990 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 10.11 (6.39 - 16.77) | 1991 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 9.95 (6.17 - 16.77) | 1993 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 9.95 (6.17 - 16.88) | 1994 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 10.03 (6.30 - 16.80) | 1992 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 10.01 (6.19 - 17.01) | 1995 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 10.13 (6.25 - 17.63) | 1996 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 10.25 (6.27 - 17.84) | 1997 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 10.4 (6.28 - 18.15) | 1998 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 10.49 (6.21 - 18.59) | 1999 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 10.53 (6.12 - 19.02) | 2000 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 10.44 (6 - 19.10) | 2001 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 10.38 (5.97 - 19.17) | 2002 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 10.29 (5.89 - 18.79) | 2003 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 9.72 (5.55 - 17.63) | 2006 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 10.15 (5.76 - 18.43) | 2004 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 9.96 (5.70 - 18.03) | 2005 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 9.73 (5.61 - 17.54) | 2007 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 9.72 (5.62 - 17.64) | 2008 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 9.67 (5.54 - 17.38) | 2009 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 9.59 (5.54 - 17.33) | 2010 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 9.39 (5.44 - 16.97) | 2011 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 8.85 (5.19 - 15.57) | 2013 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 8.6 (5.17 - 15.03) | 2014 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 9.12 (5.27 - 16.36) | 2012 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 8.35 (5.07 - 14.26) | 2015 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 8.12 (5.01 - 13.78) | 2016 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 7.91 (4.90 - 13.12) | 2017 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 7.9 (4.91 - 13.04) | 2018 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 7.85 (4.88 - 13.01) | 2019 | Modelled | IHME, GBD 2019 (accessed 2022) |
Showing out of
Show more
HBV-related deaths
National
Download| Value | Year | Type | Source |
|---|---|---|---|
| 1,071 | 2016 | Modelled | WHO |
| 717 (456 - 1,169) | 1990 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 731 (462 - 1,212) | 1991 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 758 (476 - 1,269) | 1992 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 783 (485 - 1,319) | 1993 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 813 (504 - 1,379) | 1994 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 851 (526 - 1,446) | 1995 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 894 (552 - 1,556) | 1996 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1,000 (604 - 1,746) | 1998 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 944 (577 - 1,642) | 1997 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1,100 (639 - 1,987) | 2000 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1,052 (622 - 1,864) | 1999 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1,137 (654 - 2,080) | 2001 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1,179 (678 - 2,177) | 2002 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1,216 (697 - 2,221) | 2003 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1,246 (707 - 2,262) | 2004 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1,284 (733 - 2,327) | 2006 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1,268 (726 - 2,295) | 2005 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1,327 (766 - 2,392) | 2007 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1,366 (790 - 2,479) | 2008 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1,395 (799 - 2,506) | 2009 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1,422 (824 - 2,571) | 2011 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1,413 (817 - 2,554) | 2010 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1,438 (844 - 2,532) | 2013 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1,430 (827 - 2,566) | 2012 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1,482 (915 - 2,516) | 2016 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1,451 (873 - 2,535) | 2014 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1,465 (889 - 2,502) | 2015 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1,499 (929 - 2,486) | 2017 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1,552 (964 - 2,562) | 2018 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1,597 (993 - 2,646) | 2019 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1,597 (994 - 2,646) | 2019 | Modelled | IHME, GBD 2019 (accessed 2020) |
Showing out of
Show more
Percent of liver cancer deaths attributable to HBV
National
Download
Showing out of
Show more
Coverage of 3-dose hepatitis B vaccine
Infants
Download| Value (%) | Year | Type | Source |
|---|---|---|---|
| 42 | 2019 | Survey/reported | WHO/UNICEF |
| 42 | 2020 | Survey/reported | WHO/UNICEF |
| 42 | 2021 | Survey/reported | WHO/UNICEF |
Showing out of
Show more
Number of needles/syringes per PWID per year
People who inject drugs (PWID)
Download| Value | Year | Type | Source |
|---|---|---|---|
| 0 (0 - 0) | 2016 | Survey/reported | Harm Reduction International, 2016 |
Percent of PWID accessing OST
People who inject drugs (PWID)
Download| Value (%) | Year | Type | Source |
|---|---|---|---|
| 0 | 2016 | Survey/reported | Harm Reduction International, 2016 |
HBV elimination goal
HBV National Action Plan
HepB birth dose policy
No
Eligible for HBV generic medicines
HCV National Action Plan
HCV elimination goal
Eligible for HCV generic medicines
% of substance use disorder facilities offering hepatitis testing
Few (1-10%)
Hepatitis C
Download HCV dataPrevalence of chronic HCV (RNA+/cAg)
National
Download| Value (%) | Year | Type | Source |
|---|---|---|---|
| 2.04 (1.62 - 2.57) | 2019 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 2.04 (1.63 - 2.57) | 2018 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 2.04 (1.62 - 2.57) | 2017 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 2.03 (1.62 - 2.55) | 2016 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 2.02 (1.62 - 2.55) | 2015 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 2.03 (1.62 - 2.55) | 2014 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 2.04 (1.64 - 2.56) | 2013 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 2.04 (1.65 - 2.56) | 2012 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 2.05 (1.65 - 2.58) | 2011 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 2.05 (1.65 - 2.59) | 2010 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 2.05 (1.64 - 2.58) | 2009 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 2.05 (1.65 - 2.58) | 2008 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 2.05 (1.65 - 2.57) | 2007 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 2.06 (1.65 - 2.57) | 2006 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 2.06 (1.65 - 2.59) | 2005 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 2.06 (1.66 - 2.58) | 2004 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 2.06 (1.66 - 2.59) | 2003 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 2.07 (1.66 - 2.60) | 2002 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 2.07 (1.66 - 2.61) | 2001 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 2.08 (1.66 - 2.62) | 2000 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 2.09 (1.67 - 2.62) | 1999 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 2.1 (1.68 - 2.62) | 1998 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 2.1 (1.69 - 2.62) | 1997 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 2.11 (1.71 - 2.63) | 1996 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 2.12 (1.71 - 2.63) | 1995 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 2.13 (1.72 - 2.63) | 1994 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 2.14 (1.72 - 2.66) | 1993 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 2.14 (1.71 - 2.68) | 1992 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 2.15 (1.72 - 2.69) | 1991 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 2.16 (1.71 - 2.73) | 1990 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1.96 (1.56 - 2.47) | 2019 | Modelled | IHME, GBD 2019 (accessed 2020) |
Showing out of
Show more
Women of childbearing age (15–49 years)
Download| Value (%) | Year | Type | Source |
|---|---|---|---|
| 0.79 (0.61 - 1.05) | 2019 | Modelled | Dugan et al., 2021 |
Number of people living with chronic HCV (RNA+/cAg)
National
Download| Value | Year | Type | Source |
|---|---|---|---|
| 151,549 (120,036 - 191,710) | 1990 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 153,244 (122,035 - 191,613) | 1991 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 159,344 (127,461 - 198,945) | 1992 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 165,223 (132,803 - 205,439) | 1993 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 170,961 (137,651 - 211,721) | 1994 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 177,110 (142,748 - 219,989) | 1995 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 183,310 (147,769 - 228,839) | 1996 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 190,242 (153,035 - 237,344) | 1997 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 197,811 (158,557 - 247,447) | 1998 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 205,345 (164,373 - 257,769) | 1999 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 213,109 (170,468 - 268,913) | 2000 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 221,542 (177,639 - 279,076) | 2001 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 230,425 (185,436 - 288,974) | 2002 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 239,271 (192,895 - 299,357) | 2003 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 247,867 (199,345 - 311,070) | 2004 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 256,629 (206,047 - 322,197) | 2005 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 265,552 (213,057 - 333,954) | 2006 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 273,857 (220,011 - 343,880) | 2007 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 281,784 (226,763 - 353,730) | 2008 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 288,818 (231,557 - 361,836) | 2009 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 295,016 (237,109 - 370,804) | 2010 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 302,686 (242,547 - 380,748) | 2011 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 312,155 (251,708 - 391,031) | 2012 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 322,214 (259,571 - 405,125) | 2013 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 333,005 (266,212 - 418,365) | 2014 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 345,527 (276,157 - 434,069) | 2015 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 360,086 (287,871 - 453,942) | 2016 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 374,899 (299,828 - 473,210) | 2017 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 388,921 (310,743 - 489,578) | 2018 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 402,851 (320,325 - 505,952) | 2019 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 399,531 (317,304 - 502,318) | 2019 | Modelled | IHME, GBD 2019 (accessed 2020) |
Showing out of
Show more
Women of childbearing age (15–49 years)
Download| Value | Year | Type | Source |
|---|---|---|---|
| 27,300 (21,000 - 36,200) | 2019 | Modelled | Dugan et al., 2021 |
HCV-related death rate
National
Download| Value (Deaths per 100,000) | Year | Type | Source |
|---|---|---|---|
| 5.26 (3.21 - 8.17) | 2019 | Modelled | IHME, GBD 2019 (accessed 2020) |
| 6.29 (3.90 - 9.70) | 1990 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 6.3 (3.89 - 9.83) | 1991 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 6.08 (3.74 - 9.61) | 1993 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 6.2 (3.79 - 9.72) | 1992 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 6.03 (3.70 - 9.37) | 1994 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 6.01 (3.68 - 9.31) | 1995 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 6.01 (3.69 - 9.40) | 1996 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 6.02 (3.71 - 9.42) | 1997 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 6.03 (3.77 - 9.44) | 1998 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 5.94 (3.70 - 9.18) | 2000 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 6 (3.72 - 9.31) | 1999 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 5.86 (3.63 - 9.12) | 2001 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 5.86 (3.62 - 8.98) | 2002 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 5.86 (3.61 - 9.03) | 2003 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 5.85 (3.55 - 9.09) | 2004 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 5.65 (3.42 - 9.05) | 2006 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 5.78 (3.50 - 9.13) | 2005 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 5.65 (3.44 - 9.05) | 2007 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 5.64 (3.44 - 9) | 2008 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 5.62 (3.40 - 8.98) | 2009 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 5.6 (3.41 - 9.03) | 2010 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 5.54 (3.35 - 8.86) | 2011 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 5.46 (3.29 - 8.80) | 2012 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 5.33 (3.23 - 8.44) | 2015 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 5.36 (3.25 - 8.49) | 2014 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 5.4 (3.26 - 8.65) | 2013 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 5.3 (3.23 - 8.33) | 2016 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 5.28 (3.23 - 8.27) | 2017 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 5.29 (3.24 - 8.19) | 2018 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 5.26 (3.21 - 8.17) | 2019 | Modelled | IHME, GBD 2019 (accessed 2022) |
Showing out of
Show more
HCV-related deaths
National
Download| Value | Year | Type | Source |
|---|---|---|---|
| 485 | 2016 | Modelled | WHO |
| 1,071 (653 - 1,662) | 2019 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1,071 (653 - 1,662) | 2019 | Modelled | IHME, GBD 2019 (accessed 2020) |
| 1,038 (637 - 1,609) | 2018 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 1,001 (613 - 1,567) | 2017 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 967 (589 - 1,521) | 2016 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 935 (566 - 1,481) | 2015 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 905 (549 - 1,433) | 2014 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 879 (531 - 1,407) | 2013 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 857 (515 - 1,380) | 2012 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 840 (508 - 1,341) | 2011 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 826 (503 - 1,330) | 2010 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 811 (491 - 1,294) | 2009 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 792 (483 - 1,265) | 2008 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 770 (469 - 1,235) | 2007 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 746 (451 - 1,195) | 2006 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 736 (446 - 1,162) | 2005 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 718 (435 - 1,115) | 2004 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 693 (427 - 1,067) | 2003 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 666 (412 - 1,021) | 2002 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 639 (396 - 993) | 2001 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 621 (387 - 959) | 2000 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 602 (373 - 933) | 1999 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 580 (362 - 907) | 1998 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 554 (341 - 867) | 1997 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 531 (326 - 830) | 1996 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 510 (313 - 791) | 1995 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 492 (303 - 766) | 1994 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 478 (294 - 756) | 1993 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 468 (286 - 734) | 1992 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 456 (281 - 710) | 1991 | Modelled | IHME, GBD 2019 (accessed 2022) |
| 450 (279 - 694) | 1990 | Modelled | IHME, GBD 2019 (accessed 2022) |
Showing out of
Show more
Percent of liver cancer deaths attributable to HCV
National
Download
Showing out of
Show more
Number of needles/syringes per PWID per year
People who inject drugs (PWID)
Download| Value | Year | Type | Source |
|---|---|---|---|
| 0 (0 - 0) | 2016 | Survey/reported | Harm Reduction International, 2016 |
Percent of PWID accessing OST
People who inject drugs (PWID)
Download| Value (%) | Year | Type | Source |
|---|---|---|---|
| 0 | 2016 | Survey/reported | Harm Reduction International, 2016 |
HBV elimination goal
HBV National Action Plan
HepB birth dose policy
No
Eligible for HBV generic medicines
HCV National Action Plan
HCV elimination goal
Eligible for HCV generic medicines
% of substance use disorder facilities offering hepatitis testing
Few (1-10%)
Overview
HBV elimination goal
HCV elimination goal
Prevalence (national)
Modelled
Survey/surveillance
No data available
No data available
Hepatitis related deaths (national)
Modelled
HBV
1,597
2019
(993 - 2,646)
IHME, GBD 2019 (accessed 2022)
Survey/surveillance
No data available
HBV chart
Modelled
HCV
1,071
2019
(653 - 1,662)
IHME, GBD 2019 (accessed 2022)
Survey/surveillance
No data available
HCV chart
Prevalence < 5
HBV
6.32
(%)
2020, latest modelled
(5.51 - 7.24(%))
WHO
Prevalence PWID
No data available
Birth dose vaccination coverage (national)
Survey/surveillance
No data available
Eligible for HBV generic medicines
Eligible for HCV generic medicines